In HCT116 cells, β-HB-mediated p53 Kbhb at K120, K319, and K370 sites results in lower levels of p53 acetylation and consequently, decreased activity of p53, leading to weakened tumor-suppressive function (Liu et al., 2019). The gene discussed is TP53; the disease is neoplasm.